Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes

Muscle-invasive bladder cancer has poor prognosis. If organ confined, it is potentially curable; however, across all prognostic groups, approximately half of patients will relapse. For patients with advanced disease, the median overall survival remains under two years. Systemic treatment options are...

Descripción completa

Detalles Bibliográficos
Autores principales: Giles, Megan, Crabb, Simon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335269/
https://www.ncbi.nlm.nih.gov/pubmed/37441525
http://dx.doi.org/10.2147/RRU.S386549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335269/
https://www.ncbi.nlm.nih.gov/pubmed/37441525
http://dx.doi.org/10.2147/RRU.S386549

Ejemplares similares